Global Drug Delivery Partnering Terms and Agreements 2015 - 2022

$3,995.00

The Global Drug Delivery Partnering Terms and Agreements 2015 - 2022 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

Publication date
May 2022
Number of pages
900+
Product type
Research report
Available formats
PDF document
Report edition
3
SKU
CP2102

The Global Drug Delivery Partnering Terms and Agreements 2015 - 2022 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

 

This report provides details of the latest Drug Delivery agreements announced in the life sciences since 2015.

 

The report takes the reader through a comprehensive review Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Drug Delivery partnering deals.

 

The report presents financial deal term values for Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

 

The middle section of the report explores the leading dealmakers in the Drug Delivery partnering field; both the leading deal values and most active Drug Delivery dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

 

One of the key highlights of the report is that over 1,500 online deal records of actual Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

 

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

 

The initial chapters of this report provide an orientation of Drug Delivery dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Drug Delivery dealmaking since 2015, including details of headline, upfront, milestone and royalty terms.

 

Chapter 3 provides a review of the leading Drug Delivery deals since 2015. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

 

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Drug Delivery dealmaking with a brief summary followed by a comprehensive listing of Drug Delivery deals announded by that company, as well as contract documents, where available.

 

Chapter 5 provides a comprehensive and detailed review of Drug Delivery partnering deals signed and announced since Jan 2015, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

 

Chapter 6 provides a comprehensive and detailed review of Drug Delivery partnering deals signed and announced since Jan 2015. The chapter is organized by specific Drug Delivery technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

 

A comprehensive series of appendices is provided organized by Drug Delivery partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

 

The report also includes numerous tables and figures that illustrate the trends and activities in Drug Delivery partnering and dealmaking since 2015.

 

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Drug Delivery technologies and products.

 

Key benefits

 

Global Drug Delivery Partnering Terms and Agreements 2015 - 2022 provides the reader with the following key benefits:

 

  • In-depth understanding of Drug Delivery deal trends since 2015
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Drug Delivery contracts entered into by leading biopharma companies
  • Identify most active Drug Delivery dealmakers since 2015
  • Insight into terms included in a Drug Delivery partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

 

Report scope

 

Global Drug Delivery Partnering Terms and Agreements 2015 - 2022 is intended to provide the reader with an in-depth understanding and access to Drug Delivery trends and structure of deals entered into by leading companies worldwide.

 

Drug Delivery Partnering Terms and Agreements includes:

 

  • Trends in Drug Delivery dealmaking in the biopharma industry since 2015
  • Access to headline, upfront, milestone and royalty data
  • Access to Drug Delivery contract documents
  • Leading Drug Delivery deals by value since 2015
  • Most active Drug Delivery dealmakers since 2015

 

In Global Drug Delivery Partnering Terms and Agreements 2015 - 2022, the available deals are listed by:

 

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

 

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

The Global Drug Delivery Partnering Terms and Agreements 2015 - 2022 report provides comprehensive access to available deals and contract documents for over 1,500 Drug Delivery deals.

 

Analyzing actual contract agreements allows assessment of the following:

 

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Drug Delivery Partnering Terms and Agreements 2015 - 2022 provides the reader with the following key benefits:

 

  • In-depth understanding of Drug Delivery deal trends since 2015
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Drug Delivery contracts entered into by leading biopharma companies
  • Identify most active Drug Delivery dealmakers since 2015
  • Insight into terms included in a Drug Delivery partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in Drug Delivery dealmaking

 

2.1. Introduction

2.2. Drug Delivery partnering over the years

2.3. Most active Drug Delivery dealmakers

2.4. Drug Delivery partnering by deal type

2.5. Drug Delivery partnering by therapy area

2.6. Deal terms for Drug Delivery partnering

2.6.1 Drug Delivery partnering headline values

2.6.2 Drug Delivery deal upfront payments

2.6.3 Drug Delivery deal milestone payments

2.6.4 Drug Delivery royalty rates

 

Chapter 3 – Leading Drug Delivery deals

 

3.1. Introduction

3.2. Top Drug Delivery deals by value

 

Chapter 4 – Most active Drug Delivery dealmakers

 

4.1. Introduction

4.2. Most active Drug Delivery dealmakers

4.3. Most active Drug Delivery partnering company profiles

 

Chapter 5 – Drug Delivery contracts dealmaking directory

 

5.1. Introduction

5.2. Drug Delivery contracts dealmaking directory

 

Chapter 6 – Drug Delivery dealmaking by technology type

 

 

Appendices

 

Appendix 1 – Drug Delivery deals by company A-Z

 

Appendix 2 – Drug Delivery deals by stage of development

 

Discovery

Preclinical

Phase I

Phase II

Phase III

Regulatory

Marketed

Formulation

 

Appendix 3 – Drug Delivery deals by deal type

 

Asset purchase

Assignment

Bigpharma outlicensing

Co-development

Collaborative R&D

Co-market

Co-promotion

CRADA

Cross-licensing

Development

Distribution

Equity purchase

Evaluation        

Grant

Joint venture

Licensing

Litigation

Manufacturing

Marketing

Material transfer

Option

Promotion

Research

Settlement

Spin out

Sub-license

Supply

Technology transfer

Termination

Warranty

 

Appendix 4 – Drug Delivery deals by therapy area

 

Appendix 5 – Deal type definitions

 

Appendix 6 – Further reading on dealmaking

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Drug Delivery partnering since 2015

Figure 2: Active Drug Delivery dealmaking activity since 2015

Figure 3: Drug Delivery partnering by deal type since 2015

Figure 4: Drug Delivery partnering by disease type since 2015

Figure 5: Drug Delivery deals with a headline value

Figure 6: Drug Delivery deals with an upfront value

Figure 7: Drug Delivery deals with a milestone value

Figure 8: Drug Delivery deals with a royalty rate value

Figure 9: Top Drug Delivery deals by value since 2015

Figure 10: Most active Drug Delivery dealmakers since 2015

 

Pricing options

  • $3,995: single-user
  • $5,745: multi-user
  • $10,995: single site license
  • $17,995: global site license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

3 Rivers Biotech, 3DMed, 3P Biopharmaceuticals, 3PrimeDx, 3SBio, A*STAR Agency for Science, Technology and Research, A1 Group, Abbott Laboratories, Abbvie, Abcam, ABL Bio, Abnova, Absorption Systems, Acacia Pharma, Accelis Pharma, Accord Healthcare, Accuredit Therapeutics, Acella Pharmaceuticals, Acelrx Pharmaceuticals, Acer Therapeutics, Acerus, Ache, Aclaris Therapeutics, Acorda Therapeutics, Actavis (acquired by Watson), Actelion, Acuitas Therapeutics, Acuity Pharmaceuticals, Aculys Pharma, Acura Pharmaceuticals, AdAlta, Adama, Adamas Pharmaceuticals, Adamis Pharmaceuticals, Adaptive Health, Adapt Pharma, Adare Pharma Solutions, Adhera Therapeutics, Adhesys Medical, Adhezion Biomedical, Admedus, Advanced Catheter Therapies, Advanced Cooling Therapy, Advanced Dosage Forms, Advanced Medical Solutions, Advaxis, Adverum Biotechnologies, Aegis Therapeutics, Aequus Pharmaceuticals, Aerami Therapeutics, Aerie Pharmaceuticals, Aerogen, Aeromics, AEterna Zentaris, Afaxys Pharmaceuticals, AFT Pharmaceuticals, AFYX Therapeutics, Agalimmune, Aggrega Pharma, Agile Therapeutics, Aguettant, AIM ImmunoTech, Ainos, Aires Pharmaceuticals, AIT Therapeutics, Ajax Therapeutics, Akari Therapeutics, Akorn, Albany Molecular Research, Albumedix, Alcon Laboratories, Alcove Manufacturing and Distribution, Alcyone Lifesciences, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfa Wassermann, Aligo, Alimera Sciences, ALK-Abello, Allegis Pharmaceuticals, Allergan, Alliance for Lupus Research, Alliance Pharma, AllianceRx Walgreens Prime, Allied Corp, Allogene Therapeutics, AlloSource, Almirall, Alnylam Pharmaceuticals, Alphamab Biopharmaceuticals, ALRISE Biosystems, ALS Association, Altasciences, Alteogen, Altimmune, Altum Pharmaceuticals, Altus Formulation, Aluna, Alvit LCS Pharma, Alvogen, Alzyn, Amag Pharmaceuticals, Amarantus BioSciences, Ambiopharm, Amedica, American Diabetes Association, American Renal Associates, Amerigen Pharmaceuticals, Amerinet, AmerisourceBergen, Amgen, AMI, Amneal Pharmaceuticals, AMPEL BioSolutions, AMSL, Amunix, ANANDA Scientific, Andau Medical, Andor Pharmaceuticals, Angelini Pharma, AnGes MG, Anika Therapeutics, ANI Pharmaceuticals, Anji Pharma, Anova Enterprises, Antares Pharma, Apellis Pharmaceuticals, Apexus, Aphria, ApiJect Systems, Aposense, AppianRx, Applied DNA Sciences, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apricus Biosciences, Apsen Farmacutica, AptarGroup, Aptar Pharma, Aquavit Pharmaceuticals, Aquestive Therapeutics, Aralez Pharmaceuticals, Arbutus, Arcoral Pharma, Arctic Vision, Arcturus Therapeutics, Arecor, Argentum Pharmaceuticals, argenx, Aries Pharmaceuticals, Arla Foods, Armas Pharmaceuticals, Arsia Therapeutics, ARS Pharmaceuticals, Artes Biotechnology, Artios Pharma, Art of Technology, Asahi Kasei, Asahi Kasei Kuraray Medica, Ascendia Pharmaceuticals, Ascend Therapeutics, Ascensia Diabetes Care, Asieris MediTech, Asklepios Biopharmaceutical, Aspargo Laboratories, Aspen Global, Aspen Pharmacare Canada, Assertio Therapeutics, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma Europe, AstraZeneca, ATAI Life Sciences, Athenex, Atossa Therapeutics, Aucta Pharmaceuticals, Audentes Therapeutics, Aura Biosciences, AuraVax Therapeutics, Auris Medical, Aurora Cannabis, AusHealth, Autotelic, Auxly Cannabis Group, Avacta, Avanos Medical, Avara Pharmaceutical Services, AV Cannabis, Avectas, Avellino Labs, Avenue Therapeutics, Avidea Technologies, Avior Bio, Aviragen Therapeutics, AVIR Pharma, Avita Therapeutics, AXIM Biotechnologies, Aytu BioPharma, AzurRx BioPharma, BASF, Bausch & Lomb, Bausch Health Companies, Baxter International, Bayer, Bayer Healthcare, Bazelet, Bazis NN, B Braun, BDD Pharma, Beam Therapeutics, Bebig, Becton Dickinson, Beijing Keyuan Xinhai Pharma, Bellerophon Therapeutics, Bellicum Pharmaceuticals, Ben-Gurion University, Berlin-Brandenburg Center for Regenerative Therapies, Berlin Chemie, Besins Healthcare, Bespak, Best Choice, Betaliq, BetterLife Pharma, BevCanna, Bexson Biomedical, Beyond Air, BGN Technologies, Bharat Biotech, Bial, Bigfoot Biomedical, Bill and Melinda Gates Foundation, Binex, Bio-Techne, Bio-Thera Solutions, Bioarc, BioArctic Neuroscience, biOasis Technologies, BioAxone BioSciences, Biobot Surgical, BioCardia, Biocomposites, BIOCORP, BioCorRx, BioDelivery Sciences, Bio DG, Biogen, Biohaven Pharmaceutical, Biolinear Technologies, BioLingus, Biological E, Biologix FZCo, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, BiomX, Bionaut Labs, BioNTech, Biophage Pharma, Biopharmaceutical Research Company, BiopharmX, BioQ Pharma, BioRAE, Biosensors International, BioSig Technologies, Bioventus, Birdie Biopharmaceuticals, Blackstone, BLP Management, BlueWillow Biologics, BMG Pharmaceuticals, BNC Korea, Boehringer Ingelheim, Bora Pharmaceuticals, Boston Topicals, Bpifrance, Braeburn Pharmaceuticals, Breathe ECig, Breath of Life International, Breckenbridge Pharmaceutical, Breckenridge Pharmaceuticals, BridgeBio Pharma, Bridge Medicines, Brigham and Women's Hospital, BrightFocus Foundation, Brill Pharma, Bristol-Myers Squibb, BRNT, Broda Technologies, Bryn Pharma, C-Tri, Cadila Pharmaceuticals, Calidi Biotherapeutics, California Institute for Biomedical Research, Camargo Pharmaceutical Services, Camarus, Cambridge Healthcare Innovations, Cam Med, Camurus, Canada-Israel Industrial R&D Foundation, Cancer Prevention and Research Institute of Texas, Candela, Candel Therapeutics, Canigma, Cannabics Pharmaceuticals, CannaKids, Cannaponics, CannaRoyalty, CannaSkin, Cannassure Therapeutics, Cannatrek Medical, CanniMed Therapeutics, CannPal Animal Therapeutics, CannRx Technology, Canntab Therapeutics, Canopy Growth, CanSinoBIO, Cantabria Pharma, Capcium, Capillary Biomedical, Capna Intellectual, Capnia, Cara Therapeutics, Cardinal Health, Cardiome Pharma, Cardiovascular Systems, CareTaker Medical, Caris Life Sciences, Carisma Therapeutics, Carna BioSciences, CarThera, CASI Pharmaceuticals, Cassiopea, Catalent, Cataract & Laser Institute, CBDerma Technology, CBx Data Labs, Ceapro, Cedars-Sinai Medical Center, Celator, Celdara Medical, Celgene, Cella Therapeutics, Cell Care Therapeutics, Cellectar Biosciences, Celling Biosciences, Cellix Bio, CellProThera, Cell Signaling Technology, Celltrion, Celon Pharma, Celularity, Centers for Disease Control and Prevention, Central Admixture Pharmacy Services, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Human Drug Research, Centro de Investigación Biomédica en Red de Salud Mental, Cequr, Cerebral Therapeutics, Cerenis Therapeutics, Cerner, Chansu Vascular Technologies, Charite-Universitatsmedizin, Charles River Laboratories, Chemesis, ChemWerth, Cheplapharm Arzneimittel, Chiesi Farmaceutici, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children's National Medical Center, China Medical System, China Resources Pharmaceutical Commercial Group International Trading, Chinese Academy of Sciences, Chiome Bioscience, Chrono Therapeutics, Chugai Pharmaceutical, CicloMed, Cilian, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Circassia, Citius Pharmaceuticals, Citrine Medicine, Civica Rx, Clear Guide Medical, Clearside Biomedical, Cleveland Diabetes Care, Cleveland University Hospitals, Clinical Trial and Consulting Services, CliniFusion, Clinigen, Clinvest, CloudCath, CMIC, CMS Medical, Cocoon Biotech, Codan Triplus, Colep, Collegium Pharmaceuticals, Colorcon, Columbia Care, Columbia Laboratories, Columbia University, CoMedical, Common Sensing, Companion Medical, Complix, ConserV Bioscience, Consilient Health, Consort Medical, Context Therapeutics, ConvaTec, Convoy Therapeutics, Cook Biotech, Cooper Surgical, COPD Foundation, Corium International, CorMedix, Cornerstone Animal Health, Corning, Coronado Biosciences, Corsair Pharma, CorVascular, Corvida Medical, Cosmo Pharmaceuticals, Covance, Cove, Covis Pharmaceutical, CPI International, Credence MedSystems, Crescita Therapeutics, CRISPR Therapeutics, Cristal Therapeutics, Crohn's and Colitis Foundation of America, CROMA Pharma, Crown Laboratories, CR Pharma, CrystecPharma, CSIRO, CSL Behring, CTC Bio, CTT Pharmaceutical, CTX Technology, Cumberland Pharmaceuticals, Curadigm, CURE Pharmaceutical, Currax Pharmaceuticals, Cutanea Life Sciences, Cutia Therapeutics, CVS Caremark, CV Sciences, Cybin, Cycle Pharmaceuticals, Cyclolab, Cyclo Therapeutics, Cyndea Pharma, Cynosure, Cyrano Therapeutics, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Cystic Fibrosis Trust, D&D Pharmatech, D. Western Therapeutics Institute, Daiichi Sankyo, Dalhousie University, Dance Biopharm, Danish Innovation Fund, DARA BioSciences, Dare Bioscience, DarioHealth, Dauntless Pharmaceuticals, DBV Technologies, Debiotech, Dechra Pharmaceuticals, Decibel Therapeutics, Defense Advanced Research Projects Agency, Defense Health Agency (US), Defense Threat Reduction Agency, Defymed, DEKA Research and Development, Delcath Systems, Delivra, Delpor, DelSiTech, Delta 9 Cannabis, Department of Defense, DepoMed, Dermira, DexCom, Diabeloop, Diomics, DisperSol Technologies, Diurnal, Dixie State University, DKSH, DNAtrix, Dorizoe Lifesciences, Dosecann, DOSE Medical, Dow Chemical, Dr. Reddy's Laboratories, Dr Bragi Company, Dr Kerklaan Therapeutics, DS Biopharma, Durect, Dynasil, Dyve Biosciences, Eagle Pharmaceuticals, Eastman Chemical Company, ECM Medical, ECM Therapeutics, Ecole Polytechnique Federale de Lausanne, Edenbridge Pharmaceuticals, Edge Pharma, Editas Medicine, Egalet, EG Gilero, Egis, Ei.Ventures, EirGen Pharma, Eirion Therapeutics, Eisai, Eitan Group, Elasmogen, Elcelyx Therapeutics, Elektrofi, Eleven Biotherapeutics, Eli Lilly, Elite Pharmaceuticals, Elute, EMC, EMD Serono, Emerald Health Therapeutics, Emerge Health, Emergent BioSolutions, Emery Pharma, Emisphere, Emmaus Life Sciences, Empower Clinics, Emtora Biosciences, Enable Injections, ENA Respiratory, Encore Medical, Endo Pharmaceuticals, Endotronix, Endo Ventures, Enesi Pharma, enGene, Ennaid Therapeutics, Ensemble Therapeutics, Entegra Laboratories, Enteris Biopharma, Enterprise Therapeutics, Entos Pharmaceuticals, Envisia Therapeutics, Enzymatica, EOFlow, EPI Health, EpiPharma, Eppin Pharma, Equashield, EsoCap, Espero Biopharma, Esteve, eTheRNA immunotherapies, Ethicon Endo-Surgery, Ethris, Ethypharm, Eton Pharmaceuticals, Eu Hwa, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eurofarma, European Union, European Union Regional Development Fund, EUSA Pharma, Eve & Co, Everads Therapy, Evero Health, Eversana, Evestra, Evofem, Evoke Pharma, Evonik Industries, Evox Therapeutics, Exact Therapeutics, Exactus, Exela Pharma Sciences, Exeltis, Exonate, Exopharm, ExxPharma Therapeutics, EyeCRO, Eyegate Pharmaceuticals, Eyenovia, EyePoint Pharmaceuticals, Eyevance, Fabre Kramer Pharmaceuticals, Factoria Bogar, Fagron, FairJourney Biologics, Fareva Holding, Farmalider, FarmaMondo Group, Faron Pharmaceuticals, Faulk Pharmaceuticals, Feldan Therapeutics, Felix Biotechnology, Ferndale Pharma Group, Ferrer International, Ferring Pharmaceuticals, Fidia Farmaceutici, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., Finnish Funding Agency for Technology and Innovation (TEKES), FirstString Research, First Wave Bio, Flamel Technologies, Flexion Therapeutics, Flextronics, Flower One, Flowonix, Fluum, Flynn Pharma, Foamix Pharmaceuticals, Food and Drug Administration (FDA), ForDoz Pharma, Foresee Pharmaceuticals, Formac Pharmaceuticals, Fortify Therapeutics, Fougera Pharmaceuticals, Four 20 Pharma, Fred Hutchinson Cancer Research Center, Fresenius Kabi Pharmaceuticals, FSD Pharma, Fujifilm Diosynth Biotechnologies, Futura Medical, G&W Laboratories, Gad Medical Equipment, Gaeta Therapeutics, Galen, Galena Biopharma, Gallazzi, Galvani Bioelectronics, Gardia Medical, GB Sciences, GC Pharma, Gebro Pharma, GE Healthcare, Genco Sciences, GenEdit, Genentech, GeneQuine Biotherapeutics, Genesis MedTech, Genetic Immunity, Genevant Sciences, Genexine, Genisphere, Genovi Pharmaceuticals, Genpharm, GenScience Pharmaceuticals, GenVec, Geo-Med, Georgia Tech Research Corporation, GeoVax, Ghent University, Gilead Sciences, Gland Pharma, Glaukos, GlaxoSmithKline, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Glide Technologies, Global Drug Development Centre (GDCC) China, Globe Med Tech, Glooko, Goodwin Biotechnology, Graviton Bioscience, GrayBug, Green Cross LabCell, Greene Street Pharmaceuticals, Grenco Science, Grifols, Grunenthal, Grupo Ferrer, GSW Creative Corporation Canada, Guerbet, GVK Biosciences, GW Pharmaceuticals, Gyroscope Therapeutics, H2-Pharma, Haisco Pharmaceutical, Halodine, Halo Labs, Halo Pharmaceutical, Halozyme Therapeutics, Hangzhou Chance Pharmaceuticals, Harm Reduction Therapeutics, Harrow Health, Harvard Medical School, Harvard University, Haselmeier, HCA Holdings, HCmed Innovations, HDT Bio, Health2Sync, Health Canada, Healthcare Royalty Partners, Healthy Directions, Heat Biologics, HEC Pharm, Hefei Life Science, Hefei Tianhui Incubation of Technologies, Heidelberg Pharma, Helix BioPharma, Helsinn Healthcare, HemispheRx Biopharma, Herantis, Heritage Pharmaceuticals, Heron Therapeutics, Heumann Pharma Generics, Hibernation Therapeutics, High12 Brands, Highland Therapeutics, Hikma Pharmaceuticals, Hill Dermaceuticals, Hillstream BioPharma, HLH BioPharma Vertriebs, HLS Therapeutics, Hoffmann La Roche, Hofseth BioCare, Hollister Biosciences, Hologic, Honeywell, Hookipa Pharma, Horizon 2020, Horizon Pharma plc, Horizon Therapeutics, Horus Pharma, Hospira, Hospital for Special Surgery, Hoth Therapeutics, Hovione, Huons, Hyloris Pharmaceuticals, Hyundai Pharmaceutical, I-MED Pharma, i2c Pharmaceutical Services, i2O Therapeutics, IACTA Pharmaceuticals, iBIO Institute’s PROPEL Center, ICAN, iCAN:Israel-Cannabis, ICB Pharma, Ice + Jam, iCeutica, Ichor Medical Systems, Iconovo, Idorsia, iECURE, IGEA Clinical Biophysics, Ilera Holistic Healthcare, Imbrium Therapeutics, Immune Design, Immune Pharmaceuticals, Immune System Regulation, ImmunGene, Immunocore, ImmunoForge, Immunomic, Immunovaccine, Impel NeuroPharma, Imperial Brands, Imperial College London, Impression Healthcare, Imprimis Pharmaceuticals, ImprimisRx, Incannex Healthcare, Inceptua, InCube Labs, Incyte, Indee Labs, Indegene Lifesystems, Indivior, Inexia, Infectious Disease Research Institute (IDRI), Inflammasome Therapeutics, InfusAID, Infuseon Therapeutics, InfuSystem Holdings, InfuTronix Solutions, Inhalation Sciences, Inhalon Biopharma, Inhibrx, InMed Pharmaceuticals, InnarisBio, InnoPharmax, Innovare, Innovate UK, Innovation Pharmaceuticals, Innovus Pharmaceuticals, Inolife Technologies, INO Therapeutics, Inovio, Inovio Pharmaceuticals, Inserm, InSite Vision, Insmed Inc, Inspira Pharmaceuticals, Inspirion Delivery Sciences, InspiRX Pharma, Instillo, Instituto de Ciencias Farmaceuticas, Insulet, InsuLine Medical, Insys Therapeutics, Intarcia Therapeutics, Intas Pharmaceuticals, Intec Pharma, Integral BioSystems, Integra LifeSciences, Integral Molecular, Integrated Medical Systems, IntelGenx, Intellia Therapeutics, Intellipharmaceutics, International Vaccine Institute (IVI), Intract Pharma, Intralytix, Intratus, Intravacc, Inventia Healthcare, Invion, InVixa, Ionis Pharmaceuticals, Ipsen, IQVIA, IriSys, Iroko Pharmaceuticals, iSage Rx, ISA Pharmaceuticals, Israeli National Authority for Technological Innovation, Italfarmaco, iTeos Therapeutics, Itrom Pharmaceutical Group, Ivenix, ivWatch, iX Biopharma, Jacksonville Pharmaceuticals, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Tobacco, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jiangsu Aosaikang Pharmaceutical, Jiangsu NHWA Pharmaceutical, Jiangsu Tainuo, Ji Xing Pharmaceuticals, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, JOS Pharmaceuticals, Jounce Therapeutics, Journey Medical, JSC Pharmadis, JT Pharmaceuticals, Jubilant Hollisterstier, Julphar, Juniper Pharmaceuticals, Jupiter Orphan Therapeutics, Juvenile Diabetes Research Foundation, Juyou Biotechnology, K2M, Kaleo, Kalgene Pharmaceuticals, Kali Care, Kalos Therapeutics, Kalytera Therapeutics, Kamada, Kanabo Research, Kancera, Kaneka, Karolinska Institute, Kastle Therapeutics, KBI BioPharma, KC Pharmaceuticals, Keck Graduate Institute of Applied Life Sciences, KemPharm, Kensington Pharma, Kibur Medical, Kimberly-Clark, Kindeva Drug Delivery, Kindred Bio, Kings College London, Klaria, Knight Therapeutics, KODE Biotech, Konica Minolta, Korea Advanced Institute of Science and Technology, Koru Medical Systems, Kuhnil Pharmaceuticals, Kurve Technology, KVK-Tech, Kwang Dong Pharmaceutical, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Laboratoires Thea, Laccure, Laevoroc Oncology, Lannett, Lantheus Holding, LatAm Clinical Trials, Lauren Sciences, Lawley Pharmaceuticals, Lawrence Livermore National Laboratory, Leads Biolabs, Lee's Pharmaceutical, Lee Moffitt Cancer Center, Leiden University, Leidos, Leiters, LeMaitre Vascular, Leon-nanodrugs, Leona M and Harry B Helmsley Charitable Trust, LEO Pharma, Les Laboratoires Servier, Leukocare, Lexaria Bioscience, Leyden Laboratories, LianBio, LIDDS, Lifestyle Delivery Systems, Ligand Pharmaceuticals, Lightlake Therapeutics, Lineage Cell Therapeutics, Link Health, LIPAC Oncology, Lipidor, Lipocine, LipoCure, LipoMedics, Lipomedix Pharmaceuticals, Livzon Pharmaceutical, Lobsor Pharmaceuticals, Locate Therapeutics, Locemia Solutions, Lonza, Los Altos Pharmaceuticals, Lotus Pharmaceuticals, LTR Medical, LTS Lohmann Therapie-Systeme, Lubrizol, Lucideon, Luitpold Pharmaceuticals, Lumara Health, Lumenis, Luminary Therapeutics, LumiThera, Lumosa Therapeutics, Lunatus, Lundbeck, Lung Therapeutics, Lupin, Lupin Limited, Lupin Pharmaceuticals, Luye Pharma Group, Lyndra Therapeutics, Lyomark Pharma, Lyra Therapeutics, Macquarie University, Magle Chemoswed, MainPointe, Malmo University, MangoGen Pharma, Mannin Research, MannKind Biopharmaceuticals, Mapi Pharma, Maple Leaf Green World, Marathon Asset Management, Marathon Pharmaceuticals, Marina Biotech, Marinomed Biotechnologie, Marinus Pharmaceuticals, Mark Foundation for Cancer Research, Maruho, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mast Therapeutics, Matinas Biopharma, Mati Therapeutics, Mawson Infrastructure, Maxcyte, Mayne Pharma, Mayo Clinic, MBF Therapeutics, MC2 Therapeutics, McMaster University, MD Anderson Cancer Center, MDimune, MEAgate International, Medac, Med Alliance, Medherant, Medical Developments International, MedicaSafe, Medicines360, Medidata Solutions, Medigen Vaccine Biologics, Medimetriks, MedImmune, MedinCell, Medinova, MediPharm Labs, Mediq, Medison Pharma, Medivant Healthcare, MediWound, Medlab Clinical, Medline Industries, MedLite ID, Medolife Rx, Medovate, MedPharm, Medsenic, Medspray, Medtronic, Med Trust, Meiji Seika, Memorial Sloan Kettering Cancer Center, Menarini, Menarini Asia-Pacific, Mentholatum Company, MentiNova, Merck and Co, Merck KGaA, Mercury Medical, Merial, Meroven, Merrimack Pharmaceuticals, Metagenomi, MetP Pharma, MHC Medical Products, Michael James Enterprises, Microbion, Microchips Biotech, Microdermics, Micro Labs, Micron Biomedical, MidaSol Therapeutics, Midatech, Milagro Pharmaceuticals, Milestone Scientific, MilliporeSigma, Mimetogen Pharmaceuticals, MIM Software, Mind Medicine, Miravo Healthcare, Mission Pharmacal, Mitacs, Mitsubishi Tanabe Pharma, Moberg Pharma, Mobius Therapeutics, Moderna Therapeutics, Moebius Medical, Molecular Targeting Technologies, Molteni Farmaceutici, Monarch Biosciences, Monash University, MonoSol Rx, MonoSolRx, Morgan Stanley, Motif Bio, Movi, MSD, Mundipharma, Mycrodose Therapeutics, Mylan Laboratories, Mylan Pharmaceuticals, Myosana Therapeutics, N1 Life, Nacuity Pharmaceuticals, Nanexa, Nanobiotix, Nanoform, Nanologica, Nanomerics, NanoPass Technologies, Nanopharm, NanoProteagen, NanoSmart Pharmaceuticals, NanoSphere Health Sciences, Nanotechnology Characterization Laboratory, NaNotics, NantPharma, NapaJen Pharma, Napoltec Life Sciences, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Green Biomed, National Healthcare Services (NHS), National Heart, Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Medical Products, National Research Council of Canada, National Science Foundation, Natural Sciences and Engineering Research Council of Canada, Navamedic, Navidea Biopharmaceuticals, Navigo Proteins, Nemaura Medical, Nemaura Pharma, NEMUS Bioscience, NeoCura Bio-Medical Technology, NeOnc Technologies, Neos Therapeutics, Nephron Dx, Nephron Pharmaceuticals, Nestle Health Science, Neumentum, Neurelis, Neurgain Technologies, Neurimmune Therapeutics, Neurim Pharmaceuticals, NeuroOne, NeuroRx, NeuroVive Pharmaceutical, NeuRx Pharmaceuticals, Nevada Center For Behavioral Health, Nevakar, New Age Nanotech, NewCanna Hub, Newsummit Biopharma, New York State, New York University School of Medicine, Neximmune, Nextage Therapeutics, Nextleaf Solutions, Nextremity Solutions, Nicox, Nicoya, Nightstar Therapeutics, NitricGen, Nitto Denko, NLS Pharmaceutics, Nocion Therapeutics, Nordic Pharma Group, Norwegian Research Council, Notable Labs, NovaBay Pharmaceuticals, Novaceutical Sciences, Novalere, Novaliq, Nova Mentis Life Science, Novan Therapeutics, Novarix, Novartis, Novation, Novelion Therapeutics, Noveome Biotherapeutics, Novo Nordisk, Novoteris, NRx Pharmaceuticals, NSW Medical Device Fund, NTC, Nu-med Plus, Nuance Pharma, Nucorion, NuMedii, Nuritas, Nutriband, NuVasive, Nuvisan Pharma Services, Nuvothera, NYU Grossman School of Medicine for Preclinical and Clinical Research, NZMS, Oakland Health, Oakrum Pharma, OBJ, Ocular Therapeutics, Ocular Therapeutix, Oculis, Ocumension Therapeutics, OE Meyer, Olympus Medical Systems, Omeq Medical, Omeros, Omnicell, Oncology Pharma, OncoNano Medicine, Onconova Therapeutics, Oncorus, OncoSec Medical, Oncosynergy, Oncotelic, OnDosis, One Drop, ONK Therapeutics, Ono Pharmaceutical, Onxeo, Ophthotech, Opiant Pharmaceuticals, OPKO Health, OptiBiotix, Optifye Therapeutics, Optimeos Life Sciences, Optimist Inhaler, OptiNose, Optos, Oragenics, Oramed Pharmaceuticals, Orapharma, Orbis, Orbit Biomedical, Orchestra BioMed, Orexigen Therapeutics, Orexo, Organogenesis, Orgenesis, ORIC Pharmaceuticals, Orion, Orion Biotechnology, Orphan Europe, Orsini Healthcare Specialty Pharmacy, Osivax, Osmotica Pharmaceuticals, Ossianix, OsteoRemedies, Otifex Therapeutics, Otonomy, Otsuka, Ovation Science, Ovensa, OWC Pharmaceutical Research, Owen Mumford, Oxygen Plus, Oxyrane UK, Oyster Point Pharma, Pace Wellness, Pacira Biosciences, Palatin Technologies, Palvella Therapeutics, Panaxia, Pandia Health, Panther Biotechnology, PANTHERx Specialty Pharmacy, Paragon BioTeck, Paragon Care Group, Parent Project Muscular Dystrophy, Parexel, PARI Pharma, Parker Hannifin, Par Pharmaceutical, Particle Dynamics, Particle Sciences, Patara Pharma, Pathaway, Patheon, Pax Labs, Pax Neuroscience, PDL BioPharma, PellePharm, PeptiDream, Peptron, Perennial, Performance Health, Pernix Therapeutics, Perrigo, Pfizer, Pharmaceutical Associates, Pharmaceutics International, PharmaEngine, PharmaIN, PharmaJet, Pharmalink AB, PharmaLynk, Pharmanest, Pharma Science, Pharmastrip, Pharmathen, PharmaTher, Pharmatronic, Pharos Life Corporation, Phebra, Pherin Pharmaceuticals, Phibro Animal Health, Phil, Phillips-Medisize, Phio Pharmaceuticals, Phosphagenics, Photocure ASA, Physiomics, PhytoTech Medical, PIC, Picosun, Piedmont Pharmaceuticals, Pieris, Pierre Fabre, Pierre Fabre Dermatologie, PillTracker, Piramal, Pivot Pharmaceuticals, PixarBio, PlantEXT, Plus Therapeutics, Pneuma Respiratory, Pneuma Systems, Pocono Coated Products, Pohang University Of Science And Technology, Pohl Boskamp, Polyganics, Polypeptide Therapeutic Solutions, Polyphor, Population Council, Portage Glasgow, Portage Pharmaceuticals, Portal Instruments, Poseida Therapeutics, Praxis, Preceyes, Precisa Medical Instruments, Precise Biometrics, Precision Ocular, Precision Virologics, Premier Inc, Preora Diagnostics, Presage Biosciences, Prestium Pharma, Privo Technologies, ProBioGen, Procaps, Processa Pharmaceuticals, Profusa, Progenity, Prokarium, ProLynx, Promius Pharma, Propella Therapeutics, Propeller Health, Pro Pharmaceuticals, Protalix BioTherapeutics, ProtoKinetix, Proveca, Proveris Scientific, ProvideGx, Proximagen Group, Proxy Biomedical, Psilera, PsiOxus Therapeutics, pSivida, Public Health England, Pulmatrix, Pulmodyne, Pulmonomy, Pulmonox, Pulmotect, Purdue Pharma, Purdue University, PureTech Health, Purnovate, Pyramid Biosciences, Quad Technologies, Quanta, Questcor Pharmaceuticals, QuiO Technologies, Quotient Clinical, QureTech Bio, Radient Technologies, Rafa Pharmaceuticals, Rambam Medical Center, Rani Therapeutics, Ra Pharmaceuticals, Rapid Dose Therapeutics, Raptor Pharmaceutical, Recipharm, Reckitt Benckiser, Recordati, Recro Pharma, RedHill Biopharma, Redwood Pharma, ReForm Biologics, Regeneron Pharmaceuticals, Regeneus, RegenLab, Regenxbio, Regis Technologies, ReLeaf Europe, Relief Therapeutics, Renaissance Acquisition Holdings, ReNeuron, Renovacare, Replicel Life Sciences, Respira Technologies, Respira Therapeutics, Respirent Pharmaceuticals, Respironics, Resyca, Revive Therapeutics, Revogenex, Rev Pharma, Rexahn Pharmaceuticals, Reyon Pharmaceuticals, Rhinomed, Rhoshan Pharmaceuticals, Rhythm Pharmaceuticals, Rimidi, Roche, Roivant Sciences, Roswell Park Cancer Institute, Rothman Orthopaedic Institute, Rousselot, RoverMed BioSciences, Royal Philips Electronics, Rubedo Life Sciences, Rubin Medical, Rutgers University, Salient Surgical Technologies, Samsung Electronics, Samyang Biopharmaceuticals, Sandoz, Sanofi, Sanofi-Pasteur, SaNOtize Research and Development, Sante Laboratories, Santen Pharmaceutical, Saol Therapeutics, Saraya, SarcoMed USA, Sarepta Therapeutics, Sartorius Stedim Biotech, Sato Pharmaceutical, Savara Pharma, Sawai Pharmaceuticals, Scandinavian Health, Scandion Oncology, Schott, Schreiner Group, Sciarra Laboratories, Sciecure Pharma, Science Foundation Ireland, SciSparc, scPharmaceuticals, Secarna Pharmaceuticals, Sedor Pharmaceuticals, Seelos Therapeutics, Sela Medical, SELLAS Life Sciences Group, SemaThera, Sementis, Senju Pharmaceutical, Sensory Cloud, Sentynl Therapeutics, Senzer, Seqens, Seqirus, SeraNovo, Sesen Bio, Seurat Therapeutics, SFC Fluidics, Shandong Luoxin Pharma, Shanghai Haohai Biological Technology, Shasqi, Shenzhen Smoore Technology, Shilpa Medicare, Shin Nippon Biomedical Laboratories, Shinshu University, Shionogi, Shire Laboratories, Shire Pharmaceuticals, Showa Denko, SIFI (Societa Industria Farmaceutica Italiana), Signum Biosciences, Simcere Pharmaceuticals, Simulations Plus, Sinopharm, Sinotherapeutics, Sintact Medical Systems, SipNose, Sirtex Medical, SiSaf, SiteOne Therapeutics, Skinvisible, SkyePharma, Skyline Vet Pharma, Small Business Innovation Research, SMG Pharmaceuticals, Smith Medical Partners, Smiths Medical, SocialDiabetes, Soin Neuroscience, Solasia Pharma, Soligenix, Solmic Research, Soluble Biotech, Solural Pharma, SomaServe, Sono-Tek, Sonoma Pharmaceuticals, Sophos Biotech, Sorrel Medical, Sorrento Therapeutics, Sorse Technology, Sosei Heptares, Southwest Research Institute, Spanish National Research Council, Spark Therapeutics, Sparsha, Spaulding Clinical Research, Spear Pharmaceuticals, Spectrum Pharmaceuticals, SpePharm, SpineThera, SPI Pharma, SQ Innovation, SRI International, STADA Arzneimittel, Stanford University, Starpharma, Starton Therapeutics, St Elizabeth Healthcare, Sterifarma, Stevanato, Stiefel Laboratories, Strategic Science and Technologies, Subcuject, Summit Biosciences, Sundial Growers, SunGen, Sunovion Pharmaceuticals, Sun Pharmaceutical, Sunstar Suisse, Suono Bio, Supreme Cannabis, Suzhou NeuPharma, Swedish Toxicology Sciences Research Center, SymBio Pharmaceuticals, Symvivo, Synairgen, Synartro, Syntegon, Synthetic Biologics, Syqe Medical, Tabuk Pharmaceutical, Tabula Rasa HealthCare, Tactical Relief, Taiba, Taiho, Taisho Pharmaceutical, Taiwan Liposome Company, Takeda Pharmaceutical, TALLC, Tamir Biotechnology, Tandem Diabetes Care, Tanner Pharmaceuticals, Targeted Therapy Technologies, Targetrin Therapeutics, Targovax, Tauriga Sciences, Te Arai BioFarma, TEDOR Pharma, Teewinot Life Sciences, Teijin, Teikoku Pharma USA, Tekni-Plex, Teligent, Telix Pharmaceuticals, Temple University, TerrAscend, TerSera Therapeutics, Terumo, Tesaro, Tetra Bio-Pharma, Teva Pharmaceutical Industries, Teva Pharmaceuticals USA, TFB & Associates, TFF Pharmaceuticals, TFS Corporation, TGen Drug Development, The Alchemists Kitchen, The Kroger, The Medicines Company, TheraBiologics, Therakine, Theramex, Therapeutics Incorporated, TherapeuticsMD, Therapix Bio, Therapyx, Therios Healthcare, Thin Film Electronics, Third Pole Therapeutics, Thirona Bio, Thomas Jefferson University, Threshold Pharmaceuticals, Thrive Cannabis, Tidepool, Tilray, Tioga Research, Tissue Regenix Group, Titan Pharmaceuticals, TLC Medical, to-BBB Technologies, TONIX Pharmaceuticals, Toray, Torii Pharmaceutical, Toshiba, Towa Pharmaceutical, Transdermal Delivery Solutions, Transporin, Trevi Therapeutics, Trigemina, Trinity Compound Solutions, Tripex Pharmaceuticals, TriReme Medical, TriSalus Life Sciences, Tris Pharma, Tritech, TRPharm, TRX Wound Care, TSRL, Turing Pharmaceuticals, Turku PET Center, twoXAR, Tyligand Bioscience, TypeZero Technologies, Ubiquigent, UCB, Ultragenyx Pharmaceuticals, Uluru, Unilife, UNION Therapeutics, UniQuest, United Nations Children Fund, United Therapeutics, Univar, Universidad de Cadiz, Universidad De Sevilla, Universidad de Seville, University of Alabama at Birmingham, University of Bern, University of California, Davis, University of Cologne, University of Colorado, University of Connecticut, University of Edinburgh, University of Geneva, University of Georgia, University of Glasgow, University of Houston, University of Lisbon, University of Liverpool, University of Maryland, University of Massachusetts, University of Minnesota, University of Missouri, University of New South Wales, University of North Texas, University of Notre of Dame, University of Nottingham, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Queensland, University of Sheffield, University of Sydney, University of Tennessee, University of Texas, University of Virginia, University of Wisconsin-Madison, Upadia, Uppsalagruppen Medical, Upsher-Smith, UroGen Pharma, Ursapharm, US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Biologic, US Bioservices, US Government, Utrecht University, Vaccibody, Valeant Pharmaceuticals, Valens GroWorks, Valeo Pharma, Valeritas, Vapium, Vasamed, Vaxart, Vaxess Technologies, VBI Vaccines, V ClinBio, Vect-Horus, Vectura, Veeva Systems, VerdePharmHealth, Verily, Verndari, Verrica Pharmaceuticals, Vertical Pharmaceuticals, Vesselon, Vetter, ViaCyte, Vical, Vigene Biosciences, ViiV Healthcare, Vinnova, ViralClear Pharmaceuticals, Virpax Pharmaceuticals, VisionCare Ophthalmic Technologies, VistaGen Therapeutics, Visus Therapeutics, Vitanova Biomedical, Vitruvias Therapeutics, VivaCell Biotechnology Espana, Vivera Pharmaceuticals, Vizient, Voronoi, Voyager Therapeutics, Vyera Pharmaceuticals, Vygon, VYNE Therapeutics, W.R.Grace, Wageningen University, Wakamoto Pharmaceutical, Walter Reed Army Institute of Research, Washington University in St Louis, Watson Laboratories, Welding, WellDoc, Wellman Center For Photomedicine, Werewolf Therapeutics, West Pharmaceutical Services, Windgap Medical, Winhealth Pharma Group, W L Gore, World Health Organization, Worldwide Clinical Trials, WuXi Biologics, Wuxi STA, Wyss Institute, Xanadu Bio, Xbrane Bioscience, Xcede Technologies, Xellia Pharmaceuticals, Xenon Pharmaceuticals, XERIS Pharmaceuticals, Xisle Pharma Ventures Trust, XL-Protein, Yale University, Yiling Wanzhou International Pharmaceuticals, Yissum Research Development, Yom Chai, Ypsomed, Zambon, ZappRx, Zealand Pharma, Zenabis, Zerion Pharma, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical, Zhejiang Haichang Biotechnology

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!